EUVIMEDEUVIMED entdecken
Open Access

Genetically reprogrammed exosomes for targeted prostate cancer immunotherapy

Guoyun Kao, Lei Zhang, Sunny H Kim, Qianyuan He, Zeyu Zhang, Kaiyu Shen, Jianfei Shi, Zhefu Dai, Angela Albanese, Paul M Seidler, Jacek K Pinski, Yong Zhang

Acta Biomaterialia · 2026-10

DOI: 10.1016/j.actbio.2026.10.042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-10. Verfasst von Guoyun Kao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern Califor…. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIBIB NIH HHS, National Institute of Biomedical Imaging and Bioengineering.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As one of top leading cancer deaths in men worldwide, prostate cancer (PCa) remains difficult to cure, underscoring unmet medical needs for innovative treatment options. Exosomes are cell-derived membranous vesicles. They play key roles in cell-to-cell communication and have attracted remarkable interest in drug delivery and development. In this study, we exploited a genetic approach to display both anti-human prostate-specific membrane antigen (PSMA) and anti-human CD3 antibodies on exosomal surface. Through simultaneously targeting T cells and PCa tumors, the resulting prostate cancer immunotherapeutic exosomes (PRO Exos) were designed to induce robust anti-cancer cellular immunity. In vitro and in vivo studies demonstrate potent T-cell mediated cytotoxicity specifically against PSMA-expressing PCa cells. Our findings highlight the potential of genetically reprogrammed exosomes for targeted PCa immunotherapy, representing a promising approach for battling PCa. STATEMENT OF SIGNIFICANCE: This work reports the development of genetically reprogrammed exosomes as an immunotherapeutic approach to prostate cancer. Through genetic display of two distinct types of monoclonal antibodies on exosomal surfaces, exosomes were created to simultaneously engage with human T cells and prostate cancer cells to elicit potent anti-tumor immunity. As a potentially general platform, the immunotherapeutic exosomes provide a strategy with promising efficacy and safety profiles for fighting prostate cancer by inducing host immune responses.

Schlagwörter

Stichwörter der Autor:innen

ExosomeImmunotherapyPSMAProstate cancer

Autor:innen und Institutionen

  • Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, 90089, USA.
  • Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90089, USA; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, 90089, USA.
  • Department of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, 90089, USA; Norris Comprehensive Cancer Center,…

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Kao, G., Zhang, L., Kim, S. H., He, Q., Zhang, Z., Shen, K., Shi, J., Dai, Z., Albanese, A., Seidler, P. M., Pinski, J. K., & Zhang, Y. (2026). Genetically reprogrammed exosomes for targeted prostate cancer immunotherapy. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2026.10.042

Vancouver

Kao G, Zhang L, Kim SH, He Q, Zhang Z, Shen K, et al. Genetically reprogrammed exosomes for targeted prostate cancer immunotherapy. Acta Biomaterialia. 2026. doi:10.1016/j.actbio.2026.10.042

BibTeX
@article{Kao2026,
  author = {Kao, Guoyun and Zhang, Lei and Kim, Sunny H and He, Qianyuan and Zhang, Zeyu and Shen, Kaiyu and Shi, Jianfei and Dai, Zhefu and Albanese, Angela and Seidler, Paul M and Pinski, Jacek K and Zhang, Yong},
  title = {Genetically reprogrammed exosomes for targeted prostate cancer immunotherapy},
  journal = {Acta Biomaterialia},
  year = {2026},
  doi = {10.1016/j.actbio.2026.10.042}
}
Kostenlos starten →